Health Catalyst (HCAT) Common Equity (2018 - 2026)

Health Catalyst has reported Common Equity for 9 years, with the latest figure at $138.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 63.34% year-over-year to $138.1 million; the trailing twelve-month figure through Mar 2026 stood at $138.1 million (down 63.34% YoY), and the FY2025 full-year result was $245.8 million, down 32.7% from the prior year.
• Common Equity for Q1 2026 stood at $138.1 million, down from $245.8 million in the prior quarter.
• The five-year high for Common Equity was $480.9 million in Q1 2022, with the low at $138.1 million in Q1 2026.
• Historically, Common Equity has averaged $366.7 million across 5 years, with a median of $366.9 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity jumped 78.89% — and 2026, when it plunged 63.34%.
• Health Catalyst's Common Equity stood at $425.0 million in 2022, then slipped by 13.67% to $366.9 million in 2023, then decreased by 0.47% to $365.2 million in 2024, then plunged by 32.7% to $245.8 million in 2025, then slumped by 43.79% to $138.1 million in 2026.
• The last three Common Equity figures came in at $138.1 million (Q1 2026), $245.8 million (Q4 2025), and $331.9 million (Q3 2025), per Business Quant data.